Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 9, 2014
Evaluation of 11C-BU99008, a PET ligand for the imidazoline2 binding sites in rhesus brainChristine A Parker, Nabeel Nabulsi, Daniel Holden, et al.
Journal of Medicinal Chemistry|October 10, 2012
Fumaroylamino-4,5-epoxymorphinans and related opioids with irreversible μ opioid receptor antagonist effectsHumphrey A Moynihan, Ian Derrick, Jillian H Broadbear, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 13, 2009
Proerectile effects of dopamine D2-like agonists are mediated by the D3 receptor in rats and miceGregory T Collins, Andrew Truccone, Faiza Haji-Abdi, et al.
Addiction (Abingdon, England)|June 27, 2025
Synthetic cannabinoids in e-cigarettes seized from English schoolsGyles E Cozier, Matthew Gardner, Sam Craft, et al.
The FEBS Journal|January 28, 2023
Synthetic cannabinoid receptor agonists are monoamine oxidase-A selective inhibitorsSarah A Hindson, Rachael C Andrews, Michael J Danson, et al.
ACS Omega|March 10, 2025
Field-Portable Device for Detection of Controlled and Psychoactive Substances from e-CigarettesMatthew Gardner, Celeste Bowden, Shoaib Manzoor, et al.
Analytical Chemistry|August 29, 2023
Instant Detection of Synthetic Cannabinoids on Physical Matrices, Implemented on a Low-Cost, Ultraportable DeviceGyles E Cozier, Rachael C Andrews, Anca Frinculescu, et al.
Nature|August 7, 2015
Structural insights into µ-opioid receptor activationWeijiao Huang, Aashish Manglik, A J Venkatakrishnan, et al.
Nature|July 30, 2020
Author Correction: Structural insights into μ-opioid receptor activationWeijiao Huang, Aashish Manglik, A J Venkatakrishnan, et al.
Pageof 11